[{"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0290-2017", "product_description": "Sermorelin Forte 6 mg (Sermorelin Acetate 6 mg/GHRP-6 3 mg).  Compounded by Tri-Coast Pharmacy", "product_quantity": "7 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 10192016A (04/17/2017)."}, {"country": "United States", "city": "Bellmawr", "address_1": "136 Harding Ave", "reason_for_recall": "Labeling: Labeled Error on Declared Strength; report of a 1000 ct bottle labeled as Phenobarbital 15 mg tablets actually contained 30 mg tablets", "address_2": "", "product_quantity": "unknown", "code_info": "Lot # 70952A; Exp. 11/17", "center_classification_date": "20170822", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "Phenobarbital Tablets USP, 15 mg, 1000 count bottles, Rx Only, Manufactured by West-ward Pharmaceutical Corp. Eatontown, NJ 07724, Distributed by Truxton, Inc., Bellmawr, NJ 08031, NDC 0463-6160-10", "report_date": "20170830", "classification": "Class I", "openfda": {}, "recalling_firm": "C. O. Truxton", "recall_number": "D-1111-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "77082", "termination_date": "20180911", "more_code_info": "", "recall_initiation_date": "20170420", "postal_code": "08031-2412", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0351-2017", "product_description": "Chorionic Gonadotropin Lyophilized, 20,000 unit Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "908 kits (number of vials per kit vary by prescription)", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known kit lot code:04212016@42, 06092016@164, 08122016@96.  Known vial lot code: 04132016@96, 05242016@1, 08082016@50."}, {"status": "Terminated", "city": "Broomfield", "state": "CO", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA085968"], "brand_name": ["AMITRIPTYLINE HYDROCHLORIDE"], "generic_name": ["AMITRIPTYLINE HYDROCHLORIDE"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["0781-1486", "0781-1487", "0781-1488", "0781-1489", "0781-1490", "0781-1491"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMITRIPTYLINE HYDROCHLORIDE"], "rxcui": ["856762", "856773", "856783", "856834", "856845", "856853"], "spl_id": ["9df45420-7268-454e-9624-8da48c97b7db"], "spl_set_id": ["705a2bae-031d-4218-82fe-4346542c0baa"], "package_ndc": ["0781-1486-10", "0781-1486-01", "0781-1486-31", "0781-1487-10", "0781-1487-01", "0781-1487-31", "0781-1488-10", "0781-1488-01", "0781-1488-31", "0781-1489-31", "0781-1489-01", "0781-1489-10", "0781-1490-10", "0781-1490-01", "0781-1490-31", "0781-1491-10", "0781-1491-01", "0781-1491-31"], "is_original_packager": [true], "unii": ["26LUD4JO9K"]}, "product_type": "Drugs", "event_id": "77567", "recalling_firm": "Sandoz Incorporated", "address_1": "2555 W Midway Blvd", "address_2": "N/A", "postal_code": "80020-1632", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States", "recall_number": "D-0943-2017", "product_description": "Amitriptyline HCl Tablets, USP 25 mg, Packaged in a)100-count bottles (NDC 0781-1487-01) and b) 1000-count bottles ( NDC 0781-1487-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540", "product_quantity": "38,234 bottles", "reason_for_recall": "Cross Contamination With Other Product: Imipramine", "recall_initiation_date": "20170616", "center_classification_date": "20170706", "termination_date": "20190114", "report_date": "20170712", "code_info": "Lot #: a) GR3831, GS9690, Exp. 08/2019; b) GR3832, Exp. 08/2019."}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "4 vials", "code_info": "Lot # t11-28-2016@111, Exp 5/28/2017; 02-10-2017@1,       Exp 8/9/2017.", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "PAPAVERINE/PHENT 5ML MDV 30/0.5MG/ML INJ, Injection, 30/0.5mg/mL, Rx only, 5mL glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0729-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Smyrna", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "78099", "recalling_firm": "Vi-Jon, Inc.", "address_1": "1 Swan Dr", "address_2": "N/A", "postal_code": "37167-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States and Canada", "recall_number": "D-0005-2018", "product_description": "Magnesium Citrate Oral Solution Lemon Flavor, 1.745g per fl oz,  packaged in 10 fl. oz. (296 mL) bottles, Labeled as a) CVS Health, Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895; NDC 59779-667-38, UPC 05042842790; b) Swan Citroma, Distributed by: Vi-Jon One Swan Drive Smyrna, TN 37167, NDC 0869066738,  UPC 308690667382; c)  GoodSense,   Distributed By: Geiss, Destin & Dunn, Inc. Peachtree City, GA 30269, NDC 50804-667-38, UPC 846036007374; d) Leader, Distributed By: Cardinal Health, Dublin, Ohio, 43017, NDC 3720511038, UPC 096295382433;  e) Signature Care, Distributed By: Better Living Brands, LLC. P.O. Box  99, Pleasanton, CA 94566-0009,  NDC 21130-667-38, UPC 321130779155; f) Discount Drug Mart Food Fair, Distributed By: Drug Mart-Food Fair Medina, Ohio 44256, NDC 5394301077, UPC 093351100383; g)  Sunmark, Distributed By McKesson One Post Street San Francisco, CA 94104, NDC 4934869649,  UPC 010939112330, h) Major, Distributed By: Major Pharmaceuticals 31778 Enterprise Drive Livonia, MI 48150 USA, NDC 0904630477, UPC 309046304777", "product_quantity": "348,384 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications.", "recall_initiation_date": "20170913", "center_classification_date": "20171005", "termination_date": "20200116", "report_date": "20171011", "code_info": "Lot #: a) 0326166 Exp. 07/2018; b) 0326164, Exp. 07/2018; 0326730, Exp. 08/2018; c) 0326183, Exp. 07/2018; 0326730 Exp. 08/2018; d) 0326183, Exp. 07/2018, e) 0326183, Exp. 07/2018, f) 0326730 Exp. 08/2018,g) 0326736, Exp. 08/2018, 0341351 Exp. 11/2018, h) 0326736, Exp. 08/2018.", "more_code_info": ""}, {"status": "Terminated", "city": "Chicago", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77959", "recalling_firm": "Bella Pharmaceuticals, Inc.", "address_1": "3101 W Devon Ave", "address_2": "N/A", "postal_code": "60659-1407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within USA", "recall_number": "D-1155-2017", "product_description": "MIC 25/50/50, 30mL vials, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659, 1 (877) BELLA.", "product_quantity": "5 vials", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20170815", "center_classification_date": "20170912", "termination_date": "20180423", "report_date": "20170920", "code_info": "Lot #: BPMIC30072917, Exp. 1/29/18"}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78146", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "N/A", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to one consignee in Louisiana.", "recall_number": "D-1176-2017", "product_description": "Ketorolac Trom 30 mg/mL Injection, packaged in a) 1 mL vials, NDC 61786-0741-01 (Orig: 00548-9021-00), Ref: 33631 and b) 10 x 1 mL vials per tray, NDC 61786-0741-08 (Orig: 00548-9021-00), Ref: 33632, Rx only, Packaged by: RemedyRepack Inc, Indiana, PA 15704; Mfg by: Amphastar, Rancho Cucamonga, CA  91730.", "product_quantity": "40 vials", "reason_for_recall": "Crystallization: Product is being recalled due to the manufacturer's recall due to the presence of visible particulate in vials that has been identified as crystalline ketorolac calcium salt.", "recall_initiation_date": "20170822", "center_classification_date": "20170922", "termination_date": "20180103", "report_date": "20171004", "code_info": "Lot #: a) B0158730-060816 (Mfg: XI002A6), Exp: 12/2017 ; and b) B0160669-061516 (Mfg: XI003A6), Exp 12/2017"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0302-2017", "product_description": "Testosterone Cypionate in Sesame Oil, 250 mg/mL, (5 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "1,244 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 06272016A (12/24/2016), 08242016A (02/20/2017), 09212016B (03/20/2017), 07252016A (01/21/2017), 08112016B (02/07/2017), 10252016L (02/28/2017)."}, {"status": "Terminated", "city": "Nashville", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "76103", "recalling_firm": "VIRTUS PHARMACEUTICALS OPCO II L", "address_1": "1321 Murfreesboro Pike #", "address_2": "N/A", "postal_code": "37217-2726", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0241-2017", "product_description": "VirtPrex Prenatal/Postnatal Tablets, Prescription Supplement Containing Folic Acid and DHA, packaged in 30-count bottle, Rx only, Made in Canada, NDC 76439-348-30", "product_quantity": "124,250 bottles", "reason_for_recall": "cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.", "recall_initiation_date": "20161212", "center_classification_date": "20161228", "termination_date": "20180821", "report_date": "20170104", "code_info": "Lots #: 21506124 Exp. Date 5/30/2017, 21511151 Exp. date 10/30/2017, 21511151A Exp. Data 10/30/2017, 21512163 Exp. date 11/30/2017,  21512164 Exp. date 11/30/2017"}, {"status": "Terminated", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76407", "recalling_firm": "Cherry Hill Sales Co.", "address_1": "1115 Eden Way N", "address_2": "N/A", "postal_code": "23320-2751", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Michigan, Illinois, New York, Florida, Pennsylvania .", "recall_number": "D-0484-2017", "product_description": "MakeSense PHARMA FIRST AID CREAM Lidocaine HCL 0.5%, Phenol 0.5%, 1 oz.. (28 g) tube, Made in China, Distributed by Cherry Hill Associates, Chesapeake, VA 23320, NDC 69020-210-28", "product_quantity": "7,200 cartons", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20170127", "center_classification_date": "20170218", "termination_date": "20170419", "report_date": "20170301", "code_info": "Lot # 103814; Exp. 09/17  Lot # 105306; Exp. 04/18   NDC 69020-210-28  UPC 85718005139"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78063", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-0037-2018", "product_description": "Oxytocin 15 units added to 250 mL Lactated Ringer's Injection USP in 250 mL bag, Rx Only, Compounded by PharMEDium Services, LLC. 12620 W. Airport Blvd. #130, Sugar Land, TX 77478, NDC# 71019-239-01", "product_quantity": "2232 bags", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20170901", "center_classification_date": "20171025", "termination_date": "20200124", "report_date": "20171101", "code_info": "All unexpired lots."}, {"country": "United States", "city": "Huntsville", "address_1": "150 Vintage Dr NE", "reason_for_recall": "Superpotent Drug: above specification for the assay.", "address_2": "", "product_quantity": "109,620 bottles", "code_info": "Lot #:  0000004961, Exp. 05/17; 0000005197, 0000005198, 0000005199, Exp.  07/17; 0000005201, 0000005202, 0000005203, 0000005204, Exp. 09/17; 0000005200, 0000007998, 0000007999, 0000007022, Exp. 12/17; 0000009176, Exp. 04/18; 0000012281, 0000012282, Exp. 12/18", "center_classification_date": "20170523", "distribution_pattern": "Nationwide in the USA and Puerto Rico.", "state": "AL", "product_description": "HYDROCORTISONE LOTION, USP, 2.5%, 2 FL OZ (59 mL) bottle, Rx only, Manufactured for:  QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL  35811, NDC 0603-7785-52.", "report_date": "20170531", "classification": "Class III", "openfda": {}, "recalling_firm": "Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals", "recall_number": "D-0859-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77210", "termination_date": "20180502", "more_code_info": "", "recall_initiation_date": "20170508", "postal_code": "35811-8216", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76432", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0517-2017", "product_description": "Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg, 30 count HDPE bottles, Rx Only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0093-5721-56", "product_quantity": "7,628 HDPE bottles (228,840 tablets)", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20170207", "center_classification_date": "20170310", "termination_date": "20180216", "report_date": "20170322", "code_info": "Lot 30227056A; Exp. 03/17"}, {"status": "Terminated", "city": "Irvine", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77647", "recalling_firm": "ImprimisRx CA, Inc., dba ImprimisRx", "address_1": "9257 Research Dr", "address_2": "N/A", "postal_code": "92618-4286", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-1130-2017", "product_description": "Curcumin Emulsion 10mg/ml Injection, Sterile 10 mL Multiple Dose Vial, For Slow IV Administration, Compounded for a licensed professional or patient use by ImprimisRx, Irvine, CA", "product_quantity": "2608 vials", "reason_for_recall": "Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier", "recall_initiation_date": "20170623", "center_classification_date": "20170907", "termination_date": "20190114", "report_date": "20170913", "code_info": "03212017@21B             Exp:6/19/2017;  03232017@19B Exp:6/21/2017;  03292017@27B Exp:6/27/2017;  03292017@9B Exp:6/27/2017;  04042017@21B Exp:7/3/2017;  04122017@22B Exp:7/11/2017;  04132017@14B Exp:7/12/2017;  04192017@37B Exp:7/18/2017;  04192017@17B Exp:7/18/2017;  04242017@18B Exp:7/23/2017"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0421-2017", "product_description": "Vitamin D3 in Sesame Oil Injectable 50,000 IU/mL, 5 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "335 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 04202016@1, 05052016@6, 06062016@1, 08012016@34."}, {"status": "Terminated", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076122"], "brand_name": ["MIRTAZAPINE"], "generic_name": ["MIRTAZAPINE"], "manufacturer_name": ["Mylan Institutional Inc."], "product_ndc": ["51079-086", "51079-087", "51079-088"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MIRTAZAPINE"], "rxcui": ["311725", "311726", "314111"], "spl_id": ["3a87423c-fbbb-b2a4-e063-6394a90a0db3"], "spl_set_id": ["6837b69b-2f86-42cf-b48d-b4a3c7b5413f"], "package_ndc": ["51079-086-01", "51079-086-20", "51079-087-01", "51079-087-20", "51079-088-01", "51079-088-20"], "original_packager_product_ndc": ["0378-3515", "0378-3530", "0378-3545"], "unii": ["A051Q2099Q"]}, "product_type": "Drugs", "event_id": "76463", "recalling_firm": "Mylan Institutional, Inc. (d.b.a. UDL Laboratories)", "address_1": "1718 Northrock Ct", "address_2": "N/A", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0493-2017", "product_description": "Mirtazapine Tablets, USP, 45 mg.  Rx only, 100 Tablets (10 X 10).  Manufactured by:  Mylan Pharmaceuticals Inc, Morgantown, WV ---NDC 51079-088-20", "product_quantity": "58 UD100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each)", "reason_for_recall": "Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablets commingled", "recall_initiation_date": "20170127", "center_classification_date": "20170308", "termination_date": "20190315", "report_date": "20170315", "code_info": "Batch #3083289; Exp. Date 12/2018"}, {"country": "United States", "city": "Roseville", "address_1": "8303 Sierra College Blvd Ste 128", "reason_for_recall": "Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin", "address_2": "", "product_quantity": "", "code_info": "All lots and package sizes", "center_classification_date": "20170711", "distribution_pattern": "Nationwide via internet", "state": "CA", "product_description": "ZRECT Male Enhancement Herbal Dietary Supplement Capsules, 500 mg, supplied in 2, 4 and 10  count packages, Made in Malaysia, Distributed by Organic Herbal Supply, Roseville, CA --- UPC Code 852675999451", "report_date": "20170719", "classification": "Class I", "openfda": {}, "recalling_firm": "Organic Herbal Supply", "recall_number": "D-0963-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "77055", "termination_date": "20180309", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "95661-9420", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0400-2017", "product_description": "Testosterone Cypionate in Grapeseed Oil Injectable, 100 mg/mL, a) 1mL and b) 5 mL vials, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "a ) 303 vials and b) 413 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     a) Known lot code: 04212016@5, 05102016@123, 05232016@21, 07132016@18    b) Known lot code: 04142016@7, 05042016@6, 05252016@2, 06222016@30, 07132016@25, 07282016@5."}, {"country": "United States", "city": "Bellmawr", "address_1": "136 Harding Ave", "reason_for_recall": "Labeling: Label Mixup; potentially mislabeled", "address_2": "", "product_quantity": "unknown", "code_info": "Lot # 71162A; Exp. 10/18  Lot # 70915A; Exp. 08/17  Lot # H15A55; Exp. 11/17", "center_classification_date": "20170822", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "Phenobarbital Tablets USP, 15 mg, 1000 count bottles, Rx Only, Manufactured by West-ward Pharmaceutical Corp. Eatontown, NJ 07724, Distributed by Truxton, Inc., Bellmawr, NJ 08031, NDC 0463-6160-10", "report_date": "20170830", "classification": "Class II", "openfda": {}, "recalling_firm": "C. O. Truxton", "recall_number": "D-1116-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "77082", "termination_date": "20180911", "more_code_info": "", "recall_initiation_date": "20170420", "postal_code": "08031-2412", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0551-2017", "product_description": "BRIGHTENING CREAM (Retinoic acid 0.1%, Hydroquinone 4%, kojic acid 3%, hydrocortisone 1%), Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "240 mL", "code_info": "Lot # 02-20-2017@8, Exp 4/21/2017.", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "GLUTATHIONE INH *PV* 200MG/ML SOLN, Inhalation Solution, 200mg/mL, Rx only, 4mL Plastic/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0765-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Newark", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "78151", "recalling_firm": "Gadget Island, Inc", "address_1": "5889 Central Ave", "address_2": "N/A", "postal_code": "94560-4465", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0103-2018", "product_description": "RHINO 7 Platinum 5000, capsule, Proprietary Material: 750mg, 1-capsule packets, distributed by Fifty Shades Bayside, NY 11361, UPC 617135861224", "product_quantity": "925 1-capsule packets", "reason_for_recall": "Marketed without an Approved NDA/ANDA: undeclared Active Pharmaceutical Ingredients sildenafil, desmethyl carbodenafil and tadalafil.", "recall_initiation_date": "20170915", "center_classification_date": "20171204", "termination_date": "20181204", "report_date": "20171213", "code_info": "All Lots", "more_code_info": ""}, {"country": "United States", "city": "Bristol", "address_1": "2701 Bartram Rd", "reason_for_recall": "GMP Deviations; product may not meet cGMP requirements", "address_2": "", "product_quantity": "65 gallons", "code_info": "Product Code GEN-23240", "center_classification_date": "20170524", "distribution_pattern": "Nationwide and Puerto Rico", "state": "PA", "product_description": "Shield and Protect Moisture Barrier Cream, 1.1% Clotrimazole, Net Weight 4 oz - 115 g Anti-Fungal, Gentell, Inc., Bristol, PA  NDC 61554-232-40", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Gentell, Inc", "recall_number": "D-0866-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77196", "termination_date": "20180216", "more_code_info": "", "recall_initiation_date": "20170419", "postal_code": "19007-6810", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "2 vials", "code_info": "Lot # t11-23-2016@110, Exp 5/22/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "TRI MIX 20/30/0.5 5ML MDV MCG/MG/MG/ML INJ, Injection, 20mcg/30mg/0.5mg/mL, Rx only,  5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0743-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "75450", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 SW 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the US", "recall_number": "D-0430-2017", "product_description": "Daytrana (methylphenidate transdermal system) Transdermal Patch, 30 mg over 9 hours (3.3 mg/hr), packaged in 30-count patches per box, Rx only, Manufactured by Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC 68968-5555-3.", "product_quantity": "357,420 patches", "reason_for_recall": "Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and and/or the z-statistic values.", "recall_initiation_date": "20160822", "center_classification_date": "20170110", "termination_date": "20190320", "report_date": "20170118", "code_info": "Lot #: 77306, Exp.05/2016; 77595 Exp. 07/2016; 78069, Exp.08/2016.", "more_code_info": ""}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Subpotent Drug: found to be below the specification for labeled assay.", "address_2": "", "product_quantity": "50 syringes", "code_info": "Lot: 4/19/17 1445 248-86361S, BUD\u00bf6/18/2017", "center_classification_date": "20171220", "distribution_pattern": "Nationwide in the USA to hospitals and medical facilities.", "state": "TX", "product_description": "NitroGlycerin (2 mg/10 mL in 5% Dextrose Inj, USP QS 10mL (200 mcg per mL), 10 mL Sterile single dose syringe, packaged in 5 x 5 (TWENTY FIVE) syringes per box, Rx only, Advanced Pharma, 9265 Kirby Dr., Houston, TX  77054, NDC 15082-863-61.", "report_date": "20171227", "classification": "Class I", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0115-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77503", "termination_date": "20190403", "more_code_info": "", "recall_initiation_date": "20170609", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0273-2017", "product_description": "Methylcobalamin/Folic Acid/Pyridoxine 1 mg/1 mg/50 mg/mL, 1 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "99 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.     Known lot codes (Exp Date): 05232016A (05/06/2016), 06282016B (07/01/2016), 06212016A (06/24/2016), 06142016A (06/17/2016), 06072016E (06/10/2016), 06022016B (06/05/2016), 06022016A (06/05/2016), 07262016H (07/29/2016), 07192016A (07/22/2016), 07122016A (07/15/2016), 07082016D (07/11/2016), 07062016B (07/09/2016), 08302016B (09/03/2016), 08232016D (08/26/2016), 08162016D (08/19/2016), 08092016E (08/11/2016), 08042016F (08/07/2016), 09272016D (09/30/2016), 09272016B (09/30/2016), 09202016A (09/23/2016), 09132016A (09/16/2016), 09072016B (09/10/2016), 10112016D (10/14/2016), 10042016B (10/07/2016), 11022016A (11/05/2016), 11092016A (11/12/2016), 11082016A (11/11/2016)"}, {"country": "United States", "city": "Little Rock", "address_1": "8821 Knoedl Ct", "reason_for_recall": "Lack of assurance of sterility: Product bags leaking at seam.", "address_2": "", "product_quantity": "30 bags", "code_info": "LOT # 20170511@17, Use By: 08/09/17", "center_classification_date": "20170531", "distribution_pattern": "Nationwide in the USA", "state": "AR", "product_description": "PHENYLephrine HCL in 0.9% Sodium Chloride injectable, 10 mg (Final Concentration = 0.1 mg per mL) Total Volume 100 mL, Single Dose Container bag, Preservative Free (Contains Sulfites), Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205, NDC: 70004-0810-32", "report_date": "20170607", "classification": "Class II", "openfda": {}, "recalling_firm": "SCA Pharmaceuticals", "recall_number": "D-0879-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77314", "termination_date": "20180329", "more_code_info": "", "recall_initiation_date": "20170518", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Roseville", "address_1": "8303 Sierra College Blvd Ste 128", "reason_for_recall": "Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin", "address_2": "", "product_quantity": "", "code_info": "All lots and package sizes", "center_classification_date": "20170711", "distribution_pattern": "Nationwide via internet", "state": "CA", "product_description": "TORNADO Male Enhancement Herbal Dietary Supplement Capsules, Over 4000 mg value,  supplied in 2, 4 and 10  count packages, Made in USA  Distributed by American Health Supplements, Chicago, Illinois --- UPC Code 680474228959", "report_date": "20170719", "classification": "Class I", "openfda": {}, "recalling_firm": "Organic Herbal Supply", "recall_number": "D-0966-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "77055", "termination_date": "20180309", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "95661-9420", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0268-2017", "product_description": "L-Tyrosine 10 mg/mL, (30 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "50 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.     Known lot codes (Exp Date): 07292016A (01/25/2017), 07182016E (01/14/2017), 08222016A (02/28/2017), 10192016A (10/22/2016)"}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "9 vials total (3/10mL vials and 6/50mL vials)", "code_info": "Lot # t01-25-2017@122, Exp 4/26/2017; t12-12-2016@98, Exp 6/11/2017; t01-10-2017@119, Exp 7/10/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "PROCAINE HCL SDV 2% INJ, Injection, 2%, Rx only, packaged in 10mL and 50 mL Glass/Single Dose vials, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0774-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77770", "recalling_firm": "SCA Pharmaceuticals", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1024-2017", "product_description": "PHENYLephrine HCl 25 mg in 0.9% Sodium Chloride 250 mL, Rx only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205 ---  NDC# 70004-0810-40", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; product has the potential to leak.", "recall_initiation_date": "20170714", "center_classification_date": "20170726", "termination_date": "20190501", "report_date": "20170802", "code_info": "Lots: 20170512@20 BUD: 8/10/2017; 20170504@61 BUD: 8/2/2017"}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040088"], "brand_name": ["METHADONE HYDROCHLORIDE"], "generic_name": ["METHADONE HYDROCHLORIDE"], "manufacturer_name": ["VistaPharm, LLC"], "product_ndc": ["66689-694", "66689-695"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METHADONE HYDROCHLORIDE"], "rxcui": ["991147"], "spl_id": ["2b71dd6b-0895-4349-ae79-c717c3d863e0"], "spl_set_id": ["d5bd3e97-b3f6-4bc2-9fb7-02921be35cdb"], "package_ndc": ["66689-694-30", "66689-694-79", "66689-694-88", "66689-695-79", "66689-695-30"], "is_original_packager": [true], "upc": ["0366689695792", "0366689694795"], "unii": ["229809935B"]}, "product_type": "Drugs", "event_id": "75650", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "N/A", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0465-2017", "product_description": "Methadone Hydrochloride Oral Concentrate, USP 10 mg/mL C-II, a.) 1 fl. oz. (30 mL), 12 bottles per case (NDC No. 66689-695-30), b). 1 liter (1000 mL), 4 bottles per case, (NDC No. 66689-695-79),  Rx only, Manufactured by VistaPharm, Largo, FL 33771.", "product_quantity": "127,193 bottles", "reason_for_recall": "CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.", "recall_initiation_date": "20170118", "center_classification_date": "20170202", "termination_date": "20210826", "report_date": "20170208", "code_info": "a). Lot No. 416600 (Exp. 09/17)  b). Lot No.449100 , 447500 (Exp. 04/18), 421800 (Exp. 10/17), 418600 (Exp. 09/17), 408700 (Exp. 06/17), 411900 (Exp. 07/17), 413800 (Exp. 08/17), 416500 (Exp. 09/17), 408500 (Exp. 06/17), 389800 (Exp. 01/17), 429900 (Exp. 12/17), 406300, 406100 (Exp. 05/17), 429700 (Exp. 12/17), 427300, 427100, 425900 (11/17)", "more_code_info": ""}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0259-2017", "product_description": "Glutamine 25 mg/mL (30 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "12 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.      Known lot codes (Exp date): 08032016A (01/30/2017)."}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0301-2017", "product_description": "Testosterone Cypionate/Zinc Gluconate in Sesame Oil, 200 mg/2 mg/mL, (5 ML and 10 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "1,544 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 07262016A (01/22/2017), 07132016C (01/09/2017), 08302016A (02/26/2017), 08042016D (01/31/2017), 11012016K (04/30/2017), 09202016D (03/19/2017), 10032016B (04/01/2017), 08102016A (02/06/2017), 09282016D (03/27/2017), 09222016E (03/21/2017), 09152016A (02/28/2017), 09062016B (02/28/2017), 10252016C (02/28/2017), 10042016E (04/02/2017)."}, {"status": "Terminated", "city": "Salisbury", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA040659"], "brand_name": ["MECLIZINE HYDROCHLORIDE"], "generic_name": ["MECLIZINE HYDROCLORIDE"], "manufacturer_name": ["Jubilant Cadista Pharmacuticals Inc."], "product_ndc": ["59746-121", "59746-122"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MECLIZINE HYDROCHLORIDE"], "rxcui": ["995624", "995666"], "spl_id": ["ead33f00-e158-464f-953f-ab5a9a391199"], "spl_set_id": ["9350fefc-9c00-182c-c3a9-044d4a40856f"], "package_ndc": ["59746-122-06", "59746-122-10", "59746-121-06", "59746-121-10"], "is_original_packager": [true], "upc": ["0359746121068", "0359746122065"], "unii": ["HDP7W44CIO"]}, "product_type": "Drugs", "event_id": "78461", "recalling_firm": "Jubilant Cadista Pharmaceuticals, Inc.", "address_1": "207 Kiley Dr", "address_2": "N/A", "postal_code": "21801-2249", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0082-2018", "product_description": "Meclizine hydrochloride tablets USP, 12.5 mg, 100 count HDPE bottle, Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-122-06", "product_quantity": "744 bottles", "reason_for_recall": "Marketed without an approved NDA/ANDA: Bottles were released prior to final approval.", "recall_initiation_date": "20171030", "center_classification_date": "20171116", "termination_date": "20200212", "report_date": "20171122", "code_info": "Lot # 17P0430, Exp 05/19"}, {"status": "Terminated", "city": "Concord", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77411", "recalling_firm": "Mckesson Packaging Services", "address_1": "7101 Weddington Rd NW", "address_2": "N/A", "postal_code": "28027-3412", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0928-2017", "product_description": "BuPROPion HCL Tablets, USP, 75 mg, packaged as UD 100 tablets (10x10), Rx Only, Mfg by: Sandoz Inc., 508 Carnegie Center, Suite 400, Princeton, NJ 08805, NDC: 63739-706-10", "product_quantity": "942 cartons", "reason_for_recall": "Failed Moisture Limits: Product tested out-of-specification for moisture content.", "recall_initiation_date": "20170530", "center_classification_date": "20170629", "termination_date": "20200206", "report_date": "20170705", "code_info": "Lot # 0113148, 0113149, 0113150, Exp: 04/18; 0113636, Exp: 06/18; 0114513, Exp: 10/18"}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78162", "recalling_firm": "The Harvard Drug Group", "address_1": "17177 N Laurel Park Dr Ste 233", "address_2": "", "postal_code": "48152-3951", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0013-2018", "product_description": "Alprazolam Tablets, USP, 0.25 mg, 100-count Unit Dose tablets per carton, Rx Only, Manufactured by: Watson Pharma Private Limited, Verna, Salcette Goa 403 722 INDIA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ  07054; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152, NDC 0904-5858-61.", "product_quantity": "3,935 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out-of-specification result for an unknown impurity.", "recall_initiation_date": "20170926", "center_classification_date": "20171019", "termination_date": "20200429", "report_date": "20171025", "code_info": "Lot 1274C151A, Exp 10/17", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0534-2017", "product_description": "CLINDAMYCIN 1%, AZELAIC ACID 10% CREAM, CLINDAMYCIN 1.2%/ TRETINOIN 0.05% GEL, CLINDAMYCIN 1.2%/ TRETINOIN 0.1% GEL    CLINDAMYCIN 2.5%, BENZOYL PEROXIDE 5%,  Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Arlington", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "77768", "recalling_firm": "BESTHERBS COFFEE LLC", "address_1": "2420 E Arkansas Ln Ste 216", "address_2": "N/A", "postal_code": "76014-1753", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Recalling firm only distributed to 2 consignees in TX; however recalling firm reported that product is then distributed U.S. nationwide to consumers via individuals or internet", "recall_number": "D-1144-2017", "product_description": "New Kopi Jantan Tradisional Natural Herbs Coffee, packaged in 13 gram red packets, and each box contains 25 packets, Made in Malaysia, USA Distributor: Bestherbscoffee LLC (USA), Email: bestherbscoffee@yahoo.com", "product_quantity": "6,250 packets", "reason_for_recall": "Marketed without an approved NDA/ANDA: presence of undeclared desmethyl carbodenafil and undeclared milk.", "recall_initiation_date": "20170717", "center_classification_date": "20170912", "termination_date": "20180810", "report_date": "20170920", "code_info": "UPC 557205060083 ,Exp 5/24/18"}, {"status": "Terminated", "city": "North Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091436"], "brand_name": ["LEVOFLOXACIN"], "generic_name": ["LEVOFLOXACIN"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["36000-045", "36000-046", "36000-047", "36000-048"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["LEVOFLOXACIN"], "rxcui": ["1665497", "1665507", "1665515", "1665517"], "spl_id": ["3cbc7b81-fabf-4666-951c-76f19e4f3222"], "spl_set_id": ["70c87464-1806-480a-8ebd-3f02987ff436"], "package_ndc": ["36000-045-01", "36000-046-24", "36000-047-24", "36000-048-24"], "is_original_packager": [true], "upc": ["0336000047241", "0336000045018", "0336000046244"], "nui": ["N0000193223", "M0372253"], "pharm_class_epc": ["Fluoroquinolone Antibacterial [EPC]"], "pharm_class_cs": ["Fluoroquinolones [CS]"], "unii": ["6GNT3Y5LMF"]}, "product_type": "Drugs", "event_id": "76733", "recalling_firm": "Claris Lifesciences Inc", "address_1": "1445 US Highway 130", "address_2": "", "postal_code": "08902-3100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0615-2017", "product_description": "Levofloxacin Injection in 5% Dextrose, 750 mg in 150 mL  5% Dextrose, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-048-24", "product_quantity": "24,456 units (1019 cartons x 24 bags)", "reason_for_recall": "Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.", "recall_initiation_date": "20170310", "center_classification_date": "20170324", "termination_date": "20200918", "report_date": "20170405", "code_info": "Lot #: A060040, Exp. Dec 2017", "more_code_info": ""}, {"status": "Terminated", "city": "Edmond", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77064", "recalling_firm": "Qualgen", "address_1": "14844 Bristol Park Blvd", "address_2": "N/A", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0893-2017", "product_description": "Estradiol 15 mg pellet 99.5% Estradiol USP, .5% Stearic Acid NF in 1 count, 12 count, and 30 count bottles. Sterile Office Use Only, For Subcutaneous Use Only, Rx Only, Manufactured by: Qualgen 14844 Bristol Park Blvd Edmond, OK 73013, NDC: 69761-015-01", "product_quantity": "6,227 pellets", "reason_for_recall": "CGMP deviations- Lack of Quality Assurance", "recall_initiation_date": "20170419", "center_classification_date": "20170607", "termination_date": "20210924", "report_date": "20170614", "code_info": "Lot# C028; Exp. 02/28/18  Lot# C005; Exp. 07/11/17  Lot# B142; Exp. 11/21/17  Lot# B114; Exp. 10/10/17  Lot# B099; Exp. 09/16/17  Lot# B069; Exp. 07/12/17  Lot# B048; Exp. 06/6/17"}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Fentanyl Citrate all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0809-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "North Chicago", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "78143", "recalling_firm": "AbbVie Inc.", "address_1": "1 N Waukegan Rd", "address_2": "N/A", "postal_code": "60064-1802", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "AZ", "recall_number": "D-0033-2018", "product_description": "AndroGel (testosterone gel) 1.62%, 88 gm metered-dose pump, 20.25 mg of testosterone per pump actuation, 60 metered pump actuations, Rx Only, Marketed by:  AbbVie Inc., North Chicago, IL 60064 USA.  NDC: 0051-8462-33", "product_quantity": "520 pumps", "reason_for_recall": "Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.", "recall_initiation_date": "20170908", "center_classification_date": "20171025", "termination_date": "20180423", "report_date": "20171101", "code_info": "Lot: 91122, EXP. 01/2020"}, {"status": "Terminated", "city": "Concord", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "78020", "recalling_firm": "Mckesson Packaging Services", "address_1": "7101 Weddington Rd NW", "address_2": "N/A", "postal_code": "28027-3412", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "PA, OH, IL, CO, LA", "recall_number": "D-1128-2017", "product_description": "Propafenone Hydrochloride tablets, 150 mg, packaged in 10 x 10 unit dose cards (100-count box), Rx only, Manufactured By: Watson Pharmaceuticals 311 Bonnie Circle Corona, CA 92880, NDC 63739-509-10", "product_quantity": "3966 unit-dose boxes", "reason_for_recall": "Failed moisture limits: Out of specification for moisture content.", "recall_initiation_date": "20170828", "center_classification_date": "20170906", "termination_date": "20200519", "report_date": "20170913", "code_info": "Lot#: 0112313 Exp. 12/2017; 0113376 Exp. 06/2018; 0113645 Exp. 02/2019."}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0248-2017", "product_description": "Ascorbic Acid 500 mg/mL (50 ML). Compounded by Tri-Coast Pharmacy.", "product_quantity": "201 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.      Known lot codes (Exp Date): 07192016WW (01/15/2017), 07152016G (01/11/2017), 08292016A (02/25/2017), 10262016B (02/28/2017)."}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75757", "recalling_firm": "Raritan Pharmaceuticals, Inc.", "address_1": "8 Joanna Ct", "address_2": "N/A", "postal_code": "08816-2108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY", "recall_number": "D-0233-2017", "product_description": "Kids' Relief Ear Relief Oral Liquid 0.85 fl oz. (25 mL)  3025 de'l Assomption Blvd. Montreal, QC H1N 2H2 Canada   NDC 60512-913-8 UPC 77815909639", "product_quantity": "22,704 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20161118", "center_classification_date": "20161223", "termination_date": "20200108", "report_date": "20170104", "code_info": "Lot # 35254; Exp. 05/20"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA203752"], "brand_name": ["MINIVELLE"], "generic_name": ["ESTRADIOL"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-6610", "68968-6625", "68968-6637", "68968-6650", "68968-6675"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["ESTRADIOL"], "rxcui": ["241946", "242891", "242892", "248478", "1149632", "1356979", "1356997", "1357007", "1357009", "1551622"], "spl_id": ["58e55d14-a9df-4814-9b60-b7c9ce37b0b7"], "spl_set_id": ["6c5c47ab-28ee-11e1-bfc2-0800200c9a66"], "package_ndc": ["68968-6625-8", "68968-6637-8", "68968-6650-8", "68968-6675-8", "68968-6610-8"], "is_original_packager": [true], "nui": ["M0447348", "N0000175825", "N0000000100"], "pharm_class_cs": ["Estradiol Congeners [CS]"], "pharm_class_epc": ["Estrogen [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "unii": ["4TI98Z838E"]}, "product_type": "Drugs", "event_id": "77466", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 SW 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within US", "recall_number": "D-0923-2017", "product_description": "Minivelle (estradiol Transdermal System) 0.1 mg per day, pack of 8 systems per carton, Rx only, Dist. by: Noven Therapeutics, LLC. Miami, Florida 33186.  NDC: 68968-6610-8", "product_quantity": "14434 cartons", "reason_for_recall": "Defective Delivery System: Out of specification for peel force from the release liner specification during stability testing at 18M 25C/60%RH.", "recall_initiation_date": "20170427", "center_classification_date": "20170623", "termination_date": "20190311", "report_date": "20170705", "code_info": "Lot #:: 78618, Exp. 05/2017"}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots within expiry.", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Dexamethasone Sodium Phosphate all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0845-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Lakewood", "address_1": "1200 Paco Way", "reason_for_recall": "Superpotent", "address_2": "", "product_quantity": "24,569 bags", "code_info": "a) A060174 01/13/2018, A060257  02/28/2018, A060692  05/31/2018, A061165  09/30/2018, A0A0143  01/31/2019, A0A0347  03/31/2019, and   A0A0424  04/30/2019 ;      b) A060027 12/31/2017", "center_classification_date": "20171220", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "Fluconazole Injection, USP, 2 mg/mL, a) 50 mL (NDC 336000-261-10) and b) 100 mL (NDC 33600-002-10), Rx Only,  Manufactured for: Claris LifeSciences, Inc. North Brunswick, NJ 08902 By: Claris Injectables Ltd., Gujarat, India", "report_date": "20171227", "classification": "Class III", "openfda": {}, "recalling_firm": "Renaissance Lakewood, LLC", "recall_number": "D-0124-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "78504", "termination_date": "20200401", "more_code_info": "", "recall_initiation_date": "20171111", "postal_code": "08701-5938", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077584"], "brand_name": ["PAROXETINE"], "generic_name": ["PAROXETINE"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-001", "68382-097", "68382-098", "68382-099"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PAROXETINE HYDROCHLORIDE HEMIHYDRATE"], "rxcui": ["1738483", "1738495", "1738503", "1738511"], "spl_id": ["c88d98d1-e370-4ad8-869a-603875f276cc"], "spl_set_id": ["a6bb4f0a-1555-4550-a7a4-99609674b1e7"], "package_ndc": ["68382-097-16", "68382-097-01", "68382-097-05", "68382-097-10", "68382-097-06", "68382-098-06", "68382-098-16", "68382-098-01", "68382-098-05", "68382-098-10", "68382-099-06", "68382-099-16", "68382-099-01", "68382-099-05", "68382-099-10", "68382-001-06", "68382-001-16", "68382-001-01", "68382-001-05", "68382-001-10"], "is_original_packager": [true], "upc": ["0368382098108", "0368382099105"], "unii": ["X2ELS050D8"]}, "product_type": "Drugs", "event_id": "78612", "recalling_firm": "Zydus Pharmaceuticals USA Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0101-2018", "product_description": "Paroxetine Tablets USP, 30 mg, a) 30 count (NDC 68382-099-06),   b) 500 count (NDC 68382-099-05), and c) 1000 count (NDC 68382-099-10) count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA, Inc., Pennington, NJ 08534", "product_quantity": "19812 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules: Risperidone Tablets were found in bottle of Paroxetine Tablets", "recall_initiation_date": "20171120", "center_classification_date": "20171130", "termination_date": "20200901", "report_date": "20171206", "code_info": "a) Z701308, b) Z701309, c) Z701310 exp April 2019"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77191", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0912-2017", "product_description": "Potassium PHOSphate added to 0.9% Sodium Chloride, 20 mMol 100 mL Bag, Service Code 2K5287, NDC# 61553-0287-48, Total Volume 100.00 mL  incorrectly labeled as106.67 mL, Rx Only, PharMEDium Services, LLC, 12620 W. Airport Blvd #130, Sugar Land, TX 74478", "product_quantity": "48 bags", "reason_for_recall": "Labeling: Not Elsewhere Classified: Incorrect volume printed on the product label.", "recall_initiation_date": "20170217", "center_classification_date": "20170612", "termination_date": "20170613", "report_date": "20170621", "code_info": "Lot Numbers: 170100124S, 4/11/2017; 170390015S, 5/10/2017"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0391-2017", "product_description": "Sermorelin Acetate/GHRP (2) 9 mg/9 mg Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "158 kits (number of vials per kit vary by prescription)", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known kit lot code: 05182016@215, 09062016@92.  Known vial lot code: 04252016@158, 082612016@45."}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA200403"], "brand_name": ["HYDROMORPHONE HYDROCHLORIDE"], "generic_name": ["HYDROMORPHONE HYDROCHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-1283", "0409-2552", "0409-3356", "0409-2540", "0409-3365", "0409-1312", "0409-1304"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["HYDROMORPHONE HYDROCHLORIDE"], "rxcui": ["897653", "897753", "897756", "897757", "897758", "1433251", "1724276", "1724383", "1724644"], "spl_id": ["58ff0e68-b78f-4ebd-a91b-b53bbdefc544"], "spl_set_id": ["e9c9ef18-7dfc-4322-b2fc-29b934c30f8b"], "package_ndc": ["0409-2552-11", "0409-2552-01", "0409-3356-11", "0409-3356-01", "0409-2540-11", "0409-2540-01", "0409-3365-11", "0409-3365-01", "0409-3365-10", "0409-1283-03", "0409-1283-31", "0409-1283-09", "0409-1283-10", "0409-1283-04", "0409-1283-05", "0409-1312-03", "0409-1312-30", "0409-1312-09", "0409-1312-10", "0409-1304-03", "0409-1304-31"], "is_original_packager": [true], "unii": ["L960UP2KRW"]}, "product_type": "Drugs", "event_id": "77956", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States Nationwide (including Puerto Rico) and Singapore", "recall_number": "D-1167-2017", "product_description": "HYDROmorphone HCl Injection, USP, 2 mg/mL, 1mL Single-use vial, packaged in cartons of 25 vials, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3365-11 (carton) and 0409-3365-01(vial)", "product_quantity": "115,370 vials", "reason_for_recall": "Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process.", "recall_initiation_date": "20170822", "center_classification_date": "20170915", "termination_date": "20230219", "report_date": "20170927", "code_info": "Lot: 760853A", "more_code_info": ""}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "", "code_info": "Lot #: 6/7/17 1446 515-92225P BUD: 9/5/2017; 6/2/17 1100 515-92225P BUD: 8/31/2017; 5/31/17 1415 382-92225P BUD: 8/29/2017.", "center_classification_date": "20170707", "distribution_pattern": "Nationwide with the United States", "state": "TX", "product_description": "Potassium Phosphate (USP) QS 0.9% Sodium Chloride (USP) 250 mL 15 mmol in NS 250mL Bag, Advanced Pharma, 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404. NDC15082-922-25", "report_date": "20170719", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0956-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "77595", "termination_date": "20171206", "more_code_info": "", "recall_initiation_date": "20170622", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.", "address_2": "", "product_quantity": "680 syringes", "code_info": "Lot: 4/26/17 0730 20-86367S, BUD 6/25/17; 4/24/17 0106 241-86367S, BUD 6/23/17; 5/1/17 1500 45-86367S, BUD 6/30/17; 5/9/17 1103 241-86367S, BUD 7/8/17; 5/9/17 1104 257-86367S, BUD 7/8/17; 5/12/17 0839 15-86367S, BUD 7/11/17; 5/19/17 0109 15-86367S, BUD 7/18/17; 5/22/17 0828 387-86367S, BUD 7/21/17; 5/23/17 0721 257-86367S, BUD 7/22/17; 5/24/17 0200 241-86367S, BUD 7/23/17; 5/24/17 0203 20-86367S, BUD 7/23/17; 5/26/17 0315 15-86367S, BUD 7/25/17; 5/31/17 1217 20-86367S, BUD 7/30/17", "center_classification_date": "20171220", "distribution_pattern": "Nationwide in the USA to hospitals and medical facilities.", "state": "TX", "product_description": "NitroGlycerin (1 mg/5 mL) 1 mg in 5% Dextrose Inj, USP QS 5 mL (200 mcg per mL), 5 mL Sterile single dose syringe, packaged in 8 x 5 (FORTY) syringes per box, Rx only, Advanced Pharma, 9265 Kirby Dr., Houston, TX  77054, NDC 15082-863-67.", "report_date": "20171227", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0118-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77503", "termination_date": "20190403", "more_code_info": "", "recall_initiation_date": "20170609", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77770", "recalling_firm": "SCA Pharmaceuticals", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1028-2017", "product_description": "PHENYLephrine 100 mg in 0.9% Sodium Chloride 250 mL Bag, Rx only, SCA Pharmaceuticals 882PHENYLephrine 100 mg 1 Knoedl Ct Little Rock, AR 72205 ---  NDC# 70004-0813-40", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; product has the potential to leak.", "recall_initiation_date": "20170714", "center_classification_date": "20170726", "termination_date": "20190501", "report_date": "20170802", "code_info": "Lot: 20170503@16 BUD: 8/1/2017"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0276-2017", "product_description": "MIC Ultra Cocktail (Methionine (L) 25mg/Inositol 50mg/Choline Chloride 50mg/Methylcobalamin 700mcg/Chromium Picolinate 20 mcg/Pyridoxine HCL 2mg/ml), (10 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "278 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.     Known lot codes (Exp Date): 06132016B (11/30/2016), 08042016B (12/31/2016), 08252016A (12/31/2016)"}, {"status": "Terminated", "city": "Torrance", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["DORAMA-NEO"], "generic_name": ["WATER"], "manufacturer_name": ["Sato Pharmaceutical Co., Ltd."], "product_ndc": ["49873-020"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["WATER"], "rxcui": ["1235499", "1235504"], "spl_id": ["0bde6cb8-4ea3-da1f-e063-6294a90a0fd4"], "spl_set_id": ["9cff868a-728f-46a0-9edf-6761f8adec6b"], "package_ndc": ["49873-020-01"], "is_original_packager": [true], "unii": ["059QF0KO0R"]}, "product_type": "Drugs", "event_id": "77161", "recalling_firm": "Sato Pharmaceutical Inc.", "address_1": "20695 S Western Ave Ste 240", "address_2": "", "postal_code": "90501-1834", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US: Hawaii, Guam, Saipan, SPI", "recall_number": "D-0856-2017", "product_description": "DORAMA-NEO (naphazoline hydrochloride) Eye wash, packaged in 0.5 FL OZ (15mL) bottles, Manufactured by SATO Pharmaceuticals CO., LTD. 1-5-27 Motoakasaka Minato-Ku Tokyo, Japan, NDC 49873-020-01", "product_quantity": "14,325 bottles", "reason_for_recall": "Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.", "recall_initiation_date": "20170216", "center_classification_date": "20170523", "termination_date": "20180313", "report_date": "20170531", "code_info": "Lot #: WXTZ, Exp. Sep 2019", "more_code_info": ""}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0409-2017", "product_description": "Trimix with Atropine Injectable 30 mg/3 mg/150 mcg/0.2 mg/mL, a) 2 mL b) 5 mL and 10 mL vials, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "a) 6 vials, b) 19 vials and c) 41 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     a) Known lot code: 04042016@22  b) Known lot code: 07192016@3  c) Known lot code: 04112016@13."}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075511"], "brand_name": ["FAMOTIDINE"], "generic_name": ["FAMOTIDINE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0172-5728", "0172-5729"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FAMOTIDINE"], "rxcui": ["284245", "310273"], "spl_id": ["4f26d0af-7f08-49a1-8bba-46741aa83ad5"], "spl_set_id": ["4c6f4f9e-f3f5-4ecf-9f40-887e037e8847"], "package_ndc": ["0172-5728-60", "0172-5728-70", "0172-5728-80", "0172-5729-60", "0172-5729-70"], "is_original_packager": [true], "nui": ["N0000000151", "N0000175784"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "unii": ["5QZO15J2Z8"]}, "product_type": "Drugs", "event_id": "77835", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1056-2017", "product_description": "Famotidine Tablets USP, 20 mg, 100 count bottles, Rx only,  Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA --- NDC 0172-5728-60", "product_quantity": "28,188 bottles", "reason_for_recall": "Failed Tablet/Capsule Specification; out of specification for tablet weight", "recall_initiation_date": "20170724", "center_classification_date": "20170803", "termination_date": "20180131", "report_date": "20170809", "code_info": "Lot # 3429066, exp 06/2018"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0368-2017", "product_description": "MIC/B12(M) 15 mg/50 mg/100 mg/1 mg/mL Injectable, 30 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "633 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 04222016@4, 05112016@24, 05162016@14, 06082016@8, 06222016@42, 07272016@8"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0272-2017", "product_description": "Methylcobalamin 1,000 mcg/mL, 10 mL and 30 mL.  Compounded by Tri-Coast Pharmacy", "product_quantity": "1,458 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.     Known lot codes (Exp Date): 05312016KK, 05262016A (11/22/2016), 060920161 (12/06/2016), 07262016B (01/22/2017), 07062016C (12/31/2016), 08292016B (02/25/2017), 10132016F (04/11/2017), 10252016K (02/28/2017), 07262016C (01/22/2017), 09152016 (02/28/2017)"}, {"country": "United States", "city": "Chicago", "address_1": "Suite 670", "reason_for_recall": "Subpotent Drug: Out of specification result for pramoxine hydrochloride", "address_2": "640 N. Lasalle Street", "product_quantity": "6,763 1 gram sample packets", "code_info": "Lot: 8249 - Exp. Date: 03/18   Lot: 8250 - Exp. Date: 06/18", "center_classification_date": "20170117", "distribution_pattern": "Nationwide", "state": "IL", "product_description": "Novacort Gel Sample Packets (2% hydrocortisone acetate, 1% pramoxine HCl), 10-count Carton of 1.0 g sample packets), NDC 69646-704-38 (10 ct. Carton of 1gm samples) / NDC 69646-704-01 (Individual 1gm Samples within Carton), Rx Only, Novum Pharma LLC, Chicago, IL 60654", "report_date": "20170125", "classification": "Class III", "openfda": {}, "recalling_firm": "Novum Pharma, LLC", "recall_number": "D-0433-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76233", "termination_date": "20190408", "more_code_info": "", "recall_initiation_date": "20161207", "postal_code": "60654", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "NICU STARTER TPN all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0802-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Salt Lake City", "state": "UT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76951", "recalling_firm": "Isomeric Pharmacy Solution, LLC", "address_1": "2401 S Foothill Dr Ste D", "address_2": "N/A", "postal_code": "84109-1479", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0687-2017", "product_description": "Phenylephrine 2.5%, Tropicamide 1%, 15 mL Multi-Dose Ophthalmic (spelled Opthalmic) Drops in a bottle, Rx Only, Isomeric Pharmacy Solutions, 2401 Foothill Dr, SLC, UT 84109, Part # 1300, barcode 3 70285 13001 4.", "product_quantity": "5,165 bottles", "reason_for_recall": "Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.", "recall_initiation_date": "20170406", "center_classification_date": "20170426", "termination_date": "20170830", "report_date": "20170503", "code_info": "Lot Numbers: 10003, Exp 04/05/17; 10018, Exp 04/17/17; 10023, Exp 04/23/17; 10025, Exp 04/24/17; 10027, Exp 04/29/17; 11011, 11012, Exp 05/07/17; 11024, 11026, Exp 05/14/17; 11029, Exp 05/16/17; 11030, Exp 05/17/17; 11032, Exp 05/21/17; 11045, Exp 06/04/17; 12008, Exp 06/13/17; 12014, 12015, Exp 06/20/17; 12022, 12024, Exp 06/28/17; 13001, 13002, Exp 07/03/17; 13011, 13012, Exp 07/09/17."}, {"status": "Terminated", "city": "Medak District", "state": "N/A", "country": "India", "classification": "Class III", "openfda": {"application_number": ["ANDA090061"], "brand_name": ["FINASTERIDE"], "generic_name": ["FINASTERIDE"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "product_ndc": ["31722-525"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FINASTERIDE"], "rxcui": ["310346"], "spl_id": ["2c74278f-8221-8804-e063-6394a90a7eaf"], "spl_set_id": ["cc9709ce-2d29-48bd-b46b-3f72114f2527"], "package_ndc": ["31722-525-30", "31722-525-01", "31722-525-10", "31722-525-90", "31722-525-05"], "is_original_packager": [true], "upc": ["0331722525305", "0331722525909", "0331722525107"], "nui": ["N0000175836", "N0000000126"], "pharm_class_epc": ["5-alpha Reductase Inhibitor [EPC]"], "pharm_class_moa": ["5-alpha Reductase Inhibitors [MoA]"], "unii": ["57GNO57U7G"]}, "product_type": "Drugs", "event_id": "76120", "recalling_firm": "Hetero Drugs Ltd. - Unit 1", "address_1": "Plot Nos. 213, 214, 255", "address_2": "Bonthapally Village, Jinnaram Mandal", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NJ only.", "recall_number": "D-0453-2017", "product_description": "Finasteride Tablets, USP 5 mg, 90-count bottles, Rx only, Manufactured for : Camber Pharmaceuticals, Inc. Piscataway, NJ  08854 By: Hetero Hetero Labs, Unit V Polepally, Jadcheria, Mahaboob Nagar - 509 301, India Limited NDC 31722-525-90", "product_quantity": "20,412  units", "reason_for_recall": "Failed Tablet/Capsule Specification: Tablets were found to be twice the thickness in one lot of product.", "recall_initiation_date": "20161229", "center_classification_date": "20170131", "termination_date": "20170711", "report_date": "20170208", "code_info": "Lot #: FIN16002, Exp. 03/2018", "more_code_info": ""}, {"status": "Terminated", "city": "Oberasbach", "state": "N/A", "country": "Germany", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77840", "recalling_firm": "Linde Eckstein Gmbh + Co KG", "address_1": "Flurstrasse 27a-35", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed throughout the United States", "recall_number": "D-1104-2017", "product_description": "Make Up Transparent dark tan (Titanium Dioxide) SPF 10 liquid make-up, 1 oz. Net Wt. 30 ml bottle, Art. 03240, Made in Germany, Doctor Eckstein, Linde Eckstein GMBH Co. Kg, 90522 Oberasbach, Germany, UPC 4 035219 032401.", "product_quantity": "N/A", "reason_for_recall": "Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.", "recall_initiation_date": "20170717", "center_classification_date": "20170817", "termination_date": "20180228", "report_date": "20170823", "code_info": "Lot #: 040318, Exp 03/04/2018; 261018, Exp 10/26/2018."}, {"country": "United States", "city": "Houston", "address_1": "1304 S Loop W", "reason_for_recall": "Incorrect/Undeclared Excipient; product description section of testosterone cypionate incorrectly states \"in grapeseed oil\" instead of \"in sesame oil\" . The primary panel is correct", "address_2": "", "product_quantity": "4 mL: 510 vials, 5 mL: 486 vials", "code_info": "Lot: 09122016:34, exp 09/07/2017", "center_classification_date": "20170109", "distribution_pattern": "AZ and WA", "state": "TX", "product_description": "Testosterone Cypionate 200 mg/mL in Sesame Oil, 4 mL and 5 mL vials, Rx only, For IM injection, Pharm D Solutions, Loop West Houston, TX --- NDA 69699-1709-04", "report_date": "20170118", "classification": "Class III", "openfda": {}, "recalling_firm": "Pharm D Solutions, LLC", "recall_number": "D-0426-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "75552", "termination_date": "20170511", "more_code_info": "", "recall_initiation_date": "20161012", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78590", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0125-2018", "product_description": "Amethyst (Levonorgestrel and Ethinyl Estradiol Tablets USP, 90mcg/20mcg),  28 tablet dispenser (blister foil unit), Rx only, Manufactured by: Warner Chilcott Company, LLC Fajardo, Puerto Rico 00738: Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA, NDC-52544-295-28", "product_quantity": "5,374 blister cards/28 tablets", "reason_for_recall": "Labeling: Incorrect Instructions. \"TABLETS IN WEEK 4 ARE INACTIVE\"  printed on the blister foil and package insert, however,all tablets are active.", "recall_initiation_date": "20171120", "center_classification_date": "20171220", "termination_date": "20180621", "report_date": "20171227", "code_info": "Lot # 544637A", "more_code_info": ""}, {"status": "Terminated", "city": "Pine Brook", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77545", "recalling_firm": "Alvogen, Inc", "address_1": "10 Bloomfield Ave Bldg B Ste 2", "address_2": "N/A", "postal_code": "07058-9743", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0941-2017", "product_description": "Clindamycin Injection USP; 900 mg/6 mL (150 mg/mL). 6 mL Single-dose ADD-VANTAGE Vial, Rx Only, Manufactured for Alvogen, Inc., Pine Brook, NJ 07058, NDC 47781-464-69", "product_quantity": "71,825 6 mL vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20170616", "center_classification_date": "20170703", "termination_date": "20191030", "report_date": "20170712", "code_info": "Lots: 68-105-EV; Exp. 07/31/18, 68-106-EV; Exp.  07/31/18, and 73-157-EV; Exp. 12/31/18"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0564-2017", "product_description": "MALEK'S MAGIC PLUS (retinoic acid 0.1%, hydroquinone 6%, kojic acid 3%, hydrocortisone 1%), Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75757", "recalling_firm": "Raritan Pharmaceuticals, Inc.", "address_1": "8 Joanna Ct", "address_2": "N/A", "postal_code": "08816-2108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY", "recall_number": "D-0234-2017", "product_description": "CVS pharmacy Kids' Ear Relief Oral Liquid 0.85 oz (25 mL) Distributed by: CVS Pharmacy, Inc. One CVS Drive Woonsocket RI 02895   NDC 59779-687-02 UPC 77815909639", "product_quantity": "20,448 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20161118", "center_classification_date": "20161223", "termination_date": "20200108", "report_date": "20170104", "code_info": "Lot # 33149; Exp. 01/20"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0531-2017", "product_description": "BENZOYL PEROXIDE 5% CLINDAMYCIN 1.2%, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0536-2017", "product_description": "ERYTHROMYCIN 2% IN CERAVE CREAM, ERYTHROMYCIN 3% / RETINOIC ACID 0.05%, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA007513"], "brand_name": ["LEVOPHED"], "generic_name": ["NOREPINEPHRINE BITARTRATE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-3375", "0409-1443"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["NOREPINEPHRINE BITARTRATE"], "rxcui": ["209217", "242969"], "spl_id": ["38def44d-751b-4f6c-9f00-b2bcf6988821"], "spl_set_id": ["c4de72a8-2a75-4984-ce90-e4870226dc12"], "package_ndc": ["0409-3375-14", "0409-3375-04", "0409-1443-14", "0409-1443-04"], "is_original_packager": [true], "unii": ["IFY5PE3ZRW"]}, "product_type": "Drugs", "event_id": "77956", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States Nationwide (including Puerto Rico) and Singapore", "recall_number": "D-1168-2017", "product_description": "Levophed (norepinephrine bitartrate) injection, USP, 4 mg/4 mL (1mg/mL), 4mL Fill in 5 mL Single dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3375-04", "product_quantity": "98,050 vials", "reason_for_recall": "Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process.", "recall_initiation_date": "20170822", "center_classification_date": "20170915", "termination_date": "20230219", "report_date": "20170927", "code_info": "Lot #: 753003A, Exp 9/18; 762153A, 760803A, 761053A , Exp 10/18", "more_code_info": ""}, {"status": "Terminated", "city": "Woburn", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74822", "recalling_firm": "Safecor Health, LLC", "address_1": "317 New Boston St", "address_2": "N/A", "postal_code": "01801-6231", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MA and NY", "recall_number": "D-0901-2017", "product_description": "Atorvastatin Calcium 40mg Tablet, 30-count bottles, Rx only, Pk By Safecor Health Woburn, MA 01801, NDC 60505258009", "product_quantity": "119 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20160707", "center_classification_date": "20170612", "termination_date": "20170712", "report_date": "20170621", "code_info": "Lot # A18661, Exp. 10/31/2017"}, {"status": "Terminated", "city": "Cerritos", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "75092", "recalling_firm": "United Exchange Corporation", "address_1": "17211 Valley View Ave", "address_2": "N/A", "postal_code": "90703-2414", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide, Puerto Rico and Guyana", "recall_number": "D-0496-2017", "product_description": "EYE WASH, 4 fl oz. (118 mL) bottle, OTC, Distributed by: Major Pharmaceutical, 31778 Enterprise Drive, Livonia, MI 48150, Made in Korea, NDC 0904-6491-20", "product_quantity": "46,080 bottles", "reason_for_recall": "Non-Sterility: Direct evidence of contamination for 2 lots based on FDA samples.", "recall_initiation_date": "20160902", "center_classification_date": "20170227", "termination_date": "20170619", "report_date": "20170308", "code_info": "Lot # G15905, G15907, Exp 10/2018", "more_code_info": ""}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77525", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0927-2017", "product_description": "Doxycycline Hyclate USP, active pharmaceutical ingredient,  a) 25 g packaged in a 500 cc container (NDC: 58597-8082-4), b) 100 g packaged in 16 oz container (NDC: 58597-8082-6), c) 500 g packaged in a 2500 cc container (NDC: 58597-8082-7) and a 1,000 g packaged in 1 gallon container (NDC: 58597-8082-8).  For Prescription Compounding RX Only.  Packed under cGMP conditions by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "23.5kg", "reason_for_recall": "Labeling: Not Elsewhere Classified. Manufacturer and product were discovered to be on FDA Import Alert 66-66 for misbranding of active pharmaceutical ingredient.", "recall_initiation_date": "20170601", "center_classification_date": "20170629", "termination_date": "20180531", "report_date": "20170705", "code_info": "Lot: 082815-1, EXP 06/04/2019"}, {"status": "Terminated", "city": "Oberasbach", "state": "N/A", "country": "Germany", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77840", "recalling_firm": "Linde Eckstein Gmbh + Co KG", "address_1": "Flurstrasse 27a-35", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed throughout the United States", "recall_number": "D-1108-2017", "product_description": "Make Up Perfect sand (Titanium Dioxide) SPF 10 liquid make-up, 1 oz. Net Wt. 30 ml bottle, Art. 03320, Made in Germany, Doctor Eckstein, Linde Eckstein GMBH Co. Kg, 90522 Oberasbach, Germany, UPC 4 035219 033200.", "product_quantity": "N/A", "reason_for_recall": "Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.", "recall_initiation_date": "20170717", "center_classification_date": "20170817", "termination_date": "20180228", "report_date": "20170823", "code_info": "Lot #: 200917, Exp 09/20/2017; 230218, Exp 02/23/2018; 010918, Exp 09/01/2018; 140219, Exp 02/14/2019."}, {"status": "Terminated", "city": "Memphis", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78503", "recalling_firm": "PharMEDium Services, LLC.", "address_1": "6100 Global Dr", "address_2": "N/A", "postal_code": "38141-8385", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "CA, IL", "recall_number": "D-0080-2018", "product_description": "Hydromorphone HCl 0.5 mg per mL in 0.9% Sodium Chloride Injection 1 mL, packaged in syringes, Rx Only , PharMEDium Services, LLC. 913 N. Davis Ave Cleveland, MS 38732, NDC 61553-352-40", "product_quantity": "499 syringes", "reason_for_recall": "Superpotent drug: out of specification result for potency", "recall_initiation_date": "20171013", "center_classification_date": "20171114", "termination_date": "20200124", "report_date": "20171122", "code_info": "Lot#: 172820134M, Exp 01/18"}, {"status": "Terminated", "city": "Torrance", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["SATO CLEAR"], "generic_name": ["NAPHAZOLINE HYDROCHLORIDE"], "manufacturer_name": ["Sato Pharmaceutical Co., Ltd."], "product_ndc": ["49873-044"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["NAPHAZOLINE HYDROCHLORIDE"], "rxcui": ["1043642"], "spl_id": ["0b401747-48ee-3b1d-e063-6394a90aeebd"], "spl_set_id": ["e0317a10-7b94-41c8-8d2b-0e3b6fc4ef60"], "package_ndc": ["49873-044-01"], "is_original_packager": [true], "upc": ["0349873020020"], "unii": ["MZ1131787D"]}, "product_type": "Drugs", "event_id": "77161", "recalling_firm": "Sato Pharmaceutical Inc.", "address_1": "20695 S Western Ave Ste 240", "address_2": "", "postal_code": "90501-1834", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US: Hawaii, Guam, Saipan, SPI", "recall_number": "D-0855-2017", "product_description": "SATO CLEAR (naphazoline hydrochloride) Redness Reliever Eye Drops, packaged in 0.5 FL OZ (15mL) bottles, Manufactured by SATO Pharmaceuticals CO., LTD. 1-5-27 Motoakasaka Minato-Ku Tokyo, Japan, NDC 49873-044-01", "product_quantity": "4,790 bottles", "reason_for_recall": "Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.", "recall_initiation_date": "20170216", "center_classification_date": "20170523", "termination_date": "20180313", "report_date": "20170531", "code_info": "Lot #: WXWZ, Exp. March 2019;  WXTS, Exp. October 2019", "more_code_info": ""}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "214 vials", "code_info": "Lot # t12-16-2016@73, Exp 4/18/2017; t12-27-2016@93, Exp 4/27/2017; t01-09-2017@102, Exp 5/10/2017; t01-10-2017@120, Exp 5/11/2017; 02-01-2017@78, Exp 6/1/2017; t02-08-2017@96, Exp 6/9/2017; t02-20-2017@80,   Exp 6/21/2017; t02-21-2017@122, Exp 6/23/2017; t02-23-2017@68, Exp 6/24/2017.", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "DMPS ACID *5ML* SDV 50MG/ML INJ, Injection, 50mg/ml,  Rx only, 5 mL glass/ Single Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0714-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75757", "recalling_firm": "Raritan Pharmaceuticals, Inc.", "address_1": "8 Joanna Ct", "address_2": "N/A", "postal_code": "08816-2108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY", "recall_number": "D-0232-2017", "product_description": "CVS Health Homeopathic Infants Teething Tablets 135 count bottle  Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895 NDC 59779-860-03 UPC 0504284162", "product_quantity": "45,648 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20161118", "center_classification_date": "20161223", "termination_date": "20200108", "report_date": "20170104", "code_info": "Lot #: 41116, 43436; Exp. 03/20"}, {"status": "Terminated", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77634", "recalling_firm": "PharMedium Services, Llc", "address_1": "12620 W Airport Blvd Ste 130", "address_2": "N/A", "postal_code": "77478-6200", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0988-2017", "product_description": "Potassium PHOSphate in 0.9% Sodium Chloride Injection 20 mMol in 100 mL in 150 mL Intravia Bag, Rx Only, PharMEDium Services, LLC 12620 W. Airport Blvd #130 Sugar Land, TX 77478 800-523-7749 Service Code 2K5287 NDC# 61553-287-48", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; media fill failure at manufacturer", "recall_initiation_date": "20170626", "center_classification_date": "20170714", "termination_date": "20200429", "report_date": "20170726", "code_info": "Lot: 171320001D, 8/10/2017"}, {"status": "Terminated", "city": "Pine Brook", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "76664", "recalling_firm": "Alvogen, Inc", "address_1": "10 Bloomfield Ave Bldg B Ste 2", "address_2": "N/A", "postal_code": "07058-9743", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0632-2017", "product_description": "Adalat CC (nifedipine) Extended-Release Tablets, 90 mg, 100-count bottles, Rx Only, Manufactured for Almatica Pharma Inc. Pine Brook, NJ 07058 USA, NDC 50419-70305", "product_quantity": "N/A", "reason_for_recall": "Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib", "recall_initiation_date": "20170307", "center_classification_date": "20170404", "termination_date": "20171215", "report_date": "20170412", "code_info": "Lot #: BXH66D1A, Exp. 03/2018"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0314-2017", "product_description": "TriMix, Alprostadil/Phentolamine/Papaverine 20mcg/0.5mg/30mg/mL, (1 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "8 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 06012016E (07/16/2016), 09272016B (11/06/2016), 10032016G (11/14/2016), 11012016D (12/09/2016)."}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "", "code_info": "Lot #: 5/31/17 1416 382-92425P BUD: 8/29/2017", "center_classification_date": "20170707", "distribution_pattern": "Nationwide with the United States", "state": "TX", "product_description": "Potassium Phosphate (USP) QS 0.9% Sodium Chloride (USP) 250 mL 30 mmol in NS 250mL Bag, Advanced Pharma, 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404. NDC15082-924-25", "report_date": "20170719", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0955-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "77595", "termination_date": "20171206", "more_code_info": "", "recall_initiation_date": "20170622", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "South Plainfield", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA074089"], "brand_name": ["CLOBETASOL PROPIONATE"], "generic_name": ["CLOBETASOL PROPIONATE"], "manufacturer_name": ["Cosette Pharmaceuticals, Inc."], "product_ndc": ["0713-0656"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["CLOBETASOL PROPIONATE"], "rxcui": ["861448"], "spl_id": ["0b383db5-a99b-f222-e063-6294a90adc09"], "spl_set_id": ["807d6a1a-4eca-9cf4-f514-bb1cd7b10d0f"], "package_ndc": ["0713-0656-15", "0713-0656-31", "0713-0656-37", "0713-0656-60"], "is_original_packager": [true], "upc": ["0307130656313"], "unii": ["779619577M"]}, "product_type": "Drugs", "event_id": "77401", "recalling_firm": "G & W  Laboratories, Inc.", "address_1": "111 Coolidge St", "address_2": "N/A", "postal_code": "07080-3895", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0945-2017", "product_description": "G & W Clobetasol Propionate Ointment 0.05%, packaged in a) 15 g tube (NDC 0713-0656-15), b) 30 g tube (NDC 0713-0656-31, c) 45 g tube (NDC 0713-0656-37), d) 60 g tube (NDC 0713-0656-60), Rx Only, Manufactured by G & W Laboratories, Inc. 111 Coolidge Street, South Plainfield, NJ 07080", "product_quantity": "145284 tubes", "reason_for_recall": "Failed impurities/degradation specifications: This product is being recalled due to out of specification results for Clobetasol Related Compound A, a known impurity which is a degradation product.", "recall_initiation_date": "20170602", "center_classification_date": "20170706", "termination_date": "20180509", "report_date": "20170712", "code_info": "Lot #: a) 1001090, Exp 8/ 17; 1002881, Exp 2/18; b) 1001086, Exp 8/ 17; 1001154, Exp 11/ 17; 1001156, Exp 9/17; 1002882, Exp 2/18, 1004564, Exp 7/18; c) 1001155, Exp 9/17; 1004572, Exp 7/18; d) 1001158, Exp 9/17; 1001159, Exp 10/17; 1002884, Exp 4/18"}, {"status": "Terminated", "city": "Jersey City", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA022117"], "brand_name": ["SAPHRIS"], "generic_name": ["ASENAPINE MALEATE"], "manufacturer_name": ["Allergan, Inc."], "product_ndc": ["0456-2402", "0456-2405", "0456-2410"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBLINGUAL"], "substance_name": ["ASENAPINE MALEATE"], "rxcui": ["859975", "859979", "859981", "859983", "1606337", "1606490"], "spl_id": ["ec80c35d-8289-4fda-8804-44037f339f0c"], "spl_set_id": ["5429f134-839f-4ffc-9944-55f51238def8"], "package_ndc": ["0456-2402-10", "0456-2402-06", "0456-2402-60", "0456-2402-11", "0456-2402-63", "0456-2405-10", "0456-2405-06", "0456-2405-60", "0456-2405-11", "0456-2405-63", "0456-2410-10", "0456-2410-06", "0456-2410-60", "0456-2410-11", "0456-2410-63"], "is_original_packager": [true], "unii": ["CU9463U2E2"]}, "product_type": "Drugs", "event_id": "77315", "recalling_firm": "Forest Laboratories, LLC", "address_1": "Harborside Financial Center", "address_2": "Plaza V- Suite 1900", "postal_code": "07311", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0880-2017", "product_description": "Saphris 10 mg (asenapine) sublingual tablets, 6x10 count blister packs, Rx only, Black Cherry Flavor, Manufactured by: Catalent UK Swindon, Zydis Ltd, Blagrove, Swindon, Wilshire SN5 BRU, UK Distributed by Forest Pharmaceuticals, Inc. subsidiary of Forest Laboratories, LLC, Cincinnati OH 45209 USA --- NDC 0456-2410-60; Shellpack containing 1 blister card --- NDC 0456-2410-06", "product_quantity": "40,621 blister packs", "reason_for_recall": "Labeling; Label Mixup; blister lidding foil and shell-pack labeled as 10 mg but package actually contains 5 mg tablets", "recall_initiation_date": "20170518", "center_classification_date": "20170531", "termination_date": "20181115", "report_date": "20170607", "code_info": "Lots W00733 and W00946, exp Apr 2019", "more_code_info": ""}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0283-2017", "product_description": "Quad Mix, Alprostadil/Phentolamine/Papaverine/Atropine 10mcg/1mg/19mg/190mg/ml, (1 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "10 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.     Known lot codes (Exp Date): 06072016F (07/17/2016), 08112016C (09/18/2016)."}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0356-2017", "product_description": "Fluorescein/Indocyanine, Lyophilized (P.F.), 400 mg/15 mg, 1 mL, Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "203 kits (number of vials per kit vary by prescription)", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known kit lot code: 06082016@133.  Known vial lot code: 05202016@4."}, {"status": "Terminated", "city": "Oberasbach", "state": "N/A", "country": "Germany", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77840", "recalling_firm": "Linde Eckstein Gmbh + Co KG", "address_1": "Flurstrasse 27a-35", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed throughout the United States", "recall_number": "D-1107-2017", "product_description": "Make Up Perfect pastel (Titanium Dioxide) SPF 10 liquid make-up, 1 oz. Net Wt. 30 ml bottle, Art. 03310, Made in Germany, Doctor Eckstein, Linde Eckstein GMBH Co. Kg, 90522 Oberasbach, Germany, UPC 4 035219 033101.", "product_quantity": "N/A", "reason_for_recall": "Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.", "recall_initiation_date": "20170717", "center_classification_date": "20170817", "termination_date": "20180228", "report_date": "20170823", "code_info": "Lot #: 210917, Exp 09/21/2017; 010918, Exp 09/01/2018."}, {"status": "Terminated", "city": "Annapolis", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77428", "recalling_firm": "MedPark Pharmacy, LLC", "address_1": "2002 Medical Pkwy Ste 170", "address_2": "N/A", "postal_code": "21401-3276", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed to patient in Maryland", "recall_number": "D-0888-2017", "product_description": "methylcobalamin 1mg/1mL, vial for injection,  Rx only, MedPark Pharmacy 2002 Medical Pkwy. # 170 Annapolis, MD 21401", "product_quantity": "1 (5mL) vial", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20170601", "center_classification_date": "20170607", "termination_date": "20181204", "report_date": "20170614", "code_info": "Lot #:  20170323-01, Exp.09/18/2017"}, {"status": "Terminated", "city": "Oberasbach", "state": "N/A", "country": "Germany", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77840", "recalling_firm": "Linde Eckstein Gmbh + Co KG", "address_1": "Flurstrasse 27a-35", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed throughout the United States", "recall_number": "D-1097-2017", "product_description": "Beautipharm All Day Moisturizing Balm SPF 10 (Octocrylene 4% and Octyl methoxycinnamide 4%) Facial Cream, 1.66 oz. Net. Wt. 50 ml bottle, Art. 03120 Made in Germany, Doctor Eckstein, Linde Eckstein GMBH Co. Kg, 90522 Oberasbach, Germany. UPC 4 035219 032005.", "product_quantity": "478 balms", "reason_for_recall": "Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.", "recall_initiation_date": "20170717", "center_classification_date": "20170817", "termination_date": "20180228", "report_date": "20170823", "code_info": "Lot #: 240817, Exp 08/24/17; 061217, Exp 12/06/17; 290318, Exp 03/29/18; 160818, Exp 08/16/18; 231118, Exp 11/23/18; 160119, Exp 01/16/19; 080819, Exp 08/08/19"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0549-2017", "product_description": "LACTIC ACID SOLUTION in all strengths including 20%, 30%, and 60%, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0532-2017", "product_description": "BL 20%/4% CREAM, BLT 20%/6%/4% CREAM, BLT 20%/6%/6%, BLT 20% 8% 4% CREAM, BLT 20% 8% 4% OINTMENT, BLT 20% 8% 6% CREAM, BLT 20%/ 8% /8% OINTMENT, BLT 20%/ 8% /8% CREAM, BLT 20%/ 7%/ 7% CREAM,  BLT 20%/ 10%/ 4% CREAM, BLT 20%/ 10%/ 10% CREAM, BLT 20%/ 20%/ 10% OINTMENT,BLT 7%/ 10%/ 7% CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77856", "recalling_firm": "PharMedium Services, Llc", "address_1": "12620 W Airport Blvd Ste 130", "address_2": "N/A", "postal_code": "77478-6200", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1166-2017", "product_description": "Fentanyl Citrate (Preservative Free) 20 mcg per mL (2,000 mcg per 100 mL) 100 mL total volume in a 100 mL LifeCare Bag in Sodium Chloride 0.9% Rx Only, Compounded by PharMEDium Services, LLC, Cleveland, MS 38732,   NDC 61553-605-52", "product_quantity": "295 bags", "reason_for_recall": "Labeling: Not Elsewhere Classified-  Diluent used to compound product expired prior to the expiration date assigned to the compounded product.", "recall_initiation_date": "20170406", "center_classification_date": "20170915", "termination_date": "20200113", "report_date": "20170927", "code_info": "Lot: 170850021C Exp. 06/25/17", "more_code_info": ""}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75650", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "N/A", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0457-2017", "product_description": "Nystatin Oral Suspension, USP 100,000 units per mL, a) 2 fl. oz. (60 mL), 24 bottles per case (NDC 66689-008-02), b) 16 fl. oz. (237 mL), 12 bottles per case (NDC 66689-008-16), Rx only, Manufactured by VistaPharm, Largo, FL 33771", "product_quantity": "67,955 bottles", "reason_for_recall": "CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.", "recall_initiation_date": "20170118", "center_classification_date": "20170202", "termination_date": "20210826", "report_date": "20170208", "code_info": "a) Lot No. 422600 (Exp. 10/17), 420000 (Exp. 09/17), 416100 (Exp. 08/17), 417400 (Exp. 09/17)  b) Lot No. 424200 (Exp. 10/17), 415500 (Exp. 03/18)", "more_code_info": ""}]